103
Participants
Start Date
March 7, 2018
Primary Completion Date
June 29, 2021
Study Completion Date
February 1, 2022
HCG
250 μg/0.5ml choriogonadotropine alpha, Ovitrelle, Merck Serono
CHU Nimes, Nîmes
CHU Arnaud de Villeneuve, Montpellier
Centre Hospitalier Universitaire de Nīmes
OTHER